Marta Osorio

Summary

Affiliation: Ciudad de La Habana
Country: Cuba

Publications

  1. ncbi request reprint Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study
    Marta Osorio
    Clinical Trials Unit, National Institute of Oncology and Radiobiology, Havana City, Cuba
    Cancer Biol Ther 7:488-95. 2008
  2. ncbi request reprint Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine
    Adriana Carr
    Center of Molecular Immunology and National Institute of Oncology and Radiobiology, Havana, Cuba
    J Clin Oncol 21:1015-21. 2003

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study
    Marta Osorio
    Clinical Trials Unit, National Institute of Oncology and Radiobiology, Havana City, Cuba
    Cancer Biol Ther 7:488-95. 2008
    ..The prognostic value of autoimmunity and the possibilities of dissociating anti-tumor immunity from autoimmunity deserve further research...
  2. ncbi request reprint Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine
    Adriana Carr
    Center of Molecular Immunology and National Institute of Oncology and Radiobiology, Havana, Cuba
    J Clin Oncol 21:1015-21. 2003
    ..A phase I clinical trial was performed to determine safety and immunogenicity of this vaccine...